US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

60.72

+0.51180.85%

Volume:18.57K

Turnover:1.12M

Market Cap:293.88M

PE:19.86

High:60.78

Open:60.28

Low:59.85

Close:60.21

52wk High:64.10

52wk Low:44.47

Shares:4.84M

Float Shares:4.84M

Volume Ratio:0.80

T/O Rate:0.38%

Dividend:1.52

Dividend Rate:2.51%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Axsome Therapeutics, Inc. : Truist Securities Assumes Coverage with Buy Rating; Target Price $285 vs $200

THOMSON REUTERS

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000

Lucid Diagnostics advances Medicare reimbursement and coding infrastructure

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

Shinva Medical Subsidiary Secures Class III Medical Device Approvals

Axsome Presents Alzheimer’s Agitation Caregiver Survey Results at Psych Congress 2026

China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Axsome's Auvelity Launch Shows Early Strength in Alzheimer's Agitation, RBC Says

MT Newswires Live

Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

Roivant Sciences Holds Annual Shareholder Meeting

Roivant Sciences Director Meghan FitzGerald Reports $203,159 Common Share Sale

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Guardant Health on Track for Record High Close

Stifel Nicolaus Initiates Roivant Sciences With Buy Rating, $51 Price Target

MT Newswires Live

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

Roivant Sciences Ltd : Stifel Initiates Coverage with Buy Rating; Target Price $51

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/PTH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":60.72,"timestamp":1791217657375,"preClose":60.2082,"halted":0,"volume":18570,"delay":0,"changeRate":0.008500503253709643,"floatShares":4840000,"shares":4840000,"eps":3.057033,"marketStatus":"Trading","change":0.5118,"latestTime":"10-05 12:29:12 EDT","open":60.28,"high":60.7751,"low":59.85,"amount":1121681.4816,"amplitude":0.015365,"askPrice":60.97,"askSize":1500,"bidPrice":60.86,"bidSize":1700,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":60.2082,"sharesOutstanding":2480000,"nav":59.60729,"aum":291451253.04,"dividendRate":0.025087,"bidAskSpread":0.001966,"preHourTrading":{"tag":"盘前","latestPrice":60.2082,"preClose":60.2082,"latestTime":"07:36 EDT","volume":16,"amount":963.658208,"timestamp":1791200176330,"change":0,"changeRate":0,"amplitude":0.000362},"postHourTrading":{"tag":"盘后","latestPrice":60.2,"preClose":60.2082,"latestTime":"19:30 EDT","volume":10,"amount":602.441,"timestamp":1790983804674,"change":-0.0082,"changeRate":-0.000136,"amplitude":0},"volumeRatio":0.804987,"impliedVol":0.125,"impliedVolPercentile":0.5498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.804987,"shares":4840000,"dividePrice":1.5233,"high":60.7751,"amplitude":0.015365,"preClose":60.2082,"low":59.85,"week52Low":44.47,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":60.72,"committee":0.0625,"eps":3.057033,"divideRate":0.025087,"volume":18570,"delay":0,"ttmEps":3.057033,"open":60.28,"prevYearClose":49.701,"prevWeekClose":60.2082,"prevMonthClose":60.76,"prevQuarterClose":60.76,"fiveDayClose":61.8701,"twentyDayClose":61.1284,"sixtyDayClose":59.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669310159","title":"Axsome Therapeutics, Inc. : Truist Securities Assumes Coverage with Buy Rating; Target Price $285 vs $200","url":"https://stock-news.laohu8.com/highlight/detail?id=2669310159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669310159?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:03","pubTimestamp":1790154221,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","AXSM","BK4585","LU2324357040.USD","BK4007","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669120310","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120310","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120310?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:00","pubTimestamp":1790114446,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 1,7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL64Mcy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LU0889565916.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","BBH","BK4139","IE0009355771.USD","RVMD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","PTH","IE0009354923.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","CANC","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147769","title":"Lucid Diagnostics advances Medicare reimbursement and coding infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147769","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147769?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:29","pubTimestamp":1790083753,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics ( ($LUCD) ) has provided an update. On September 22, 2026, Lucid Diagnostics announced key advances in payment, billing and codin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCDL","AGNG","MHIP","PINK","PTH","LCIZ","RXD","SG9999014013.SGD","MEDI","LU0433182093.SGD","LUCD","BK4551","RSPH","BMED","DVXV","LU0868494617.USD","MHIG","FHLC","IE00B3S45H60.SGD","LU1150488135.SGD","PSCH","REZ","LU0708994859.HKD","HCA","TRUH","HTEC","TMED","IHF","XLVI","LU0203347892.USD","JHMH","LU1267930490.SGD","BK4585","XLVX","IHI","IE00B775SV38.USD","CURE","LU1084165304.USD","BK4588","LCID","SG9999014039.USD","LU0310800379.SGD","IYH","LNGR","BK4082","IEHS","LU0310799852.SGD","BK4099","XHE","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142210","title":"AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142210","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142210?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:55","pubTimestamp":1790081700,"startTime":"0","endTime":"0","summary":"Daraxonrasib is an important therapeutic advance, but pancreatic cancer is not a simple disease where one successful targeted drug makes additional therapeutic development unnecessary. We believe Ampligen has the potential to complement and extend therapies such as daraxonrasib by helping to overcome the immune biological barriers that have h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366375/29489/en/aim-immunotech-highlights-ampligen-s-potential-role-in-the-evolving-pancreatic-cancer-treatment-landscape-following-fda-approval-of-revolution-medicines-daraxonrasib.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","IE0009355771.USD","LU0889565916.HKD","PTH","RVMD","IE00B2B36J28.USD","LU0109394709.USD","BBH","BK4139","IE0002141913.USD","LABU","IDNA","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0009354923.USD","IE00BJT1NW94.SGD","BK4588","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144047","title":"Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144047","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144047?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:30","pubTimestamp":1790080200,"startTime":"0","endTime":"0","summary":"New Preclinical PDAC Package for PRP Shows >90% Tumor-Growth Inhibition & >2.5-Fold Survival Benefit; Company Contrasts Mechanism, Breadth, & Development Role Against Erasca’s Phase 1 ERAS-0015 Datase","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366329/0/en/propanc-biopharma-highlights-differentiated-prp-pancreatic-cancer-data-versus-emerging-pan-ras-program-eras-0015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0724618433.USD","LU1861220033.SGD","BK4548","BBH","01698","BK4141","BK4571","PDX","BK4585","LU0109394709.USD","LU0269904917.USD","BK4535","IE00BYTNYN87.SGD","LU0359202008.SGD","LU1861219969.SGD","BK4139","BK4509","LU1548497426.USD","IE00B12V2V27.USD","LU1720051017.SGD","BK4108","BK4588","ONG","LU1023057109.AUD","PPCB","SG9999011746.SGD","CANC","BK4531","IE00BJT1NW94.SGD","LU1854103824.USD","LU1854104046.USD","BK4512","TME","PTH","ONX","BK4565","IDNA","RVMD","ERAS","IE0009354923.USD","LU0320765992.SGD","LU0509642566.USD","BK4605","LU2357305700.SGD","ON","LU2360107325.USD","LU2298322129.HKD","IE00BFTCPJ56.SGD","IE00BYQNZ168.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107418547","title":"Shinva Medical Subsidiary Secures Class III Medical Device Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1107418547","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107418547?lang=en_us&edition=fundamental","pubTime":"2026-09-22 15:40","pubTimestamp":1790062838,"startTime":"0","endTime":"0","summary":"Shinva Medical Instrument Co., Ltd. (600587.SH) has announced that its subsidiary, Shinva Surgical Instruments Co., Ltd., recently received the Medical Device Registration Certificates issued by...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","GDOC","09996","600587","AGNG","BK0028","BK1583","MDEV","HART","BK0188","IEIH","BK1574","RSPH","LNGR","MEDX","159883","PTH","LGHT","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150647","title":"Axsome Presents Alzheimer’s Agitation Caregiver Survey Results at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150647?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:01","pubTimestamp":1789988488,"startTime":"0","endTime":"0","summary":"Axsome presents Alzheimer’s agitation caregiver survey results at Psych Congress 2026Axsome highlighted caregiver survey results at Psych Congress 2026 in New Orleans on Sept. 17-18, 2026.Polling of 7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL5lLRbf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014039.USD","IE00BQXX3F31.USD","LU2324357040.USD","BK4112","IE00BN0W2T93.GBP","BK4505","BK4588","IE00B3QW5Z07.USD","NDAQ","AXSM","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","PTH","SG9999014005.SGD","IE00BGHQF748.EUR","BK4007","BCDF","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","LU2095319765.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126968451","title":"China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1126968451","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126968451?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:34","pubTimestamp":1789979675,"startTime":"0","endTime":"0","summary":"China-Singapore Suzhou Industrial Park Development Group Co., Ltd. (601512.SH) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK0273","HELX","BK1583","601512","PTH","LNGR","09996","MDEV","MEDX","HART","WDNA","AGNG","RSPH","IEIH","GDOC","BK1100","BK1574","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112501840","title":"Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112501840","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112501840?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:17","pubTimestamp":1789975044,"startTime":"0","endTime":"0","summary":"Citi has issued a research report following the joint release of the 15th Five-Year Plan for the Pharmaceutical Industry Development by the Ministry of Industry and Information Technology and other...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","LU1267930227.SGD","LU0196878994.USD","IYF","LU0359202008.SGD","LU0417516738.SGD","LU0314109678.HKD","IE00BZ08YR35.GBP","LU0052750758.USD","LU0417516902.SGD","159883","LU2125154778.USD","LU2328871848.SGD","01276","LU2236285917.USD","LU2360032135.SGD","LU2097828631.EUR","IE00BSNM7G36.USD","LU0320765646.SGD","LU0072461881.USD","LU0326950275.SGD","BK4534","LU0106831901.USD","LU0348825331.USD","LU0463099449.HKD","LU0607220059.USD","BK1610","BK4588","LU0315179316.USD","02269","LU1668664300.SGD","LU0039217434.USD","LU0162691827.USD","LU0314106906.USD","LU1366192091.USD","BK4585","LU0516422440.USD","LU0098860793.USD","LU0029874061.USD","LU0516422952.EUR","MEDX","03347","LU0072913022.USD","LU1688375341.USD","LU0823426308.USD","LU0561508036.HKD","LU1152091168.USD","LU0708995583.HKD","BK1191","LU1162221912.USD","BK4566","LU0456827905.SGD","BK4504","LU2456880835.USD","LU2097828474.EUR","LU0502904849.HKD","LU0310800965.SGD","06990","LU3063872942.SGD","LU0880133367.SGD","LU0980610538.SGD","LU1506573853.SGD","LU1226287875.USD","LU0130517989.USD","MDEV","LU0128522744.USD","LU1226288253.USD","LU1188198961.HKD","LU1328277881.USD","LU0501845795.SGD","LU1960683339.HKD","IE0008369823.USD","BK1515","LU1969619763.USD","159992","LU1951186391.HKD","LU0572944931.SGD","SG9999002463.SGD","LU0455707207.USD","LU0170899867.USD","LU0307460666.USD","LU1242518931.SGD","01801","LU1244550494.USD","BK1521","LU1144417596.USD","LU1226287529.USD","BK4559","HK0000165453.HKD","01093","HART","LU1008478684.HKD","BK1100","LU0043850808.USD","LU1794554557.SGD","PTH","BK1141","LU2039709279.SGD","BK4207","LU0203347892.USD","LU0348735423.USD","LU0516423091.SGD","SG9999004220.SGD","LU1807302812.USD","LU1023057109.AUD","LU1226287792.SGD","BK1574","LU2488822045.USD","LU0634319403.HKD","LU1720050803.USD","IBBQ","LU0067412154.USD","LU0203345920.USD","LU1201861249.SGD","LU2242644610.SGD","LU0320764243.SGD","GDOC","LU1242518857.USD","BK1583","LU0819121731.USD","LU1813983027.USD","LU0130102774.USD","LU2125154935.USD","FTXO","LU0456846285.SGD","LU0359201885.HKD","RSPH","IE00B0JY6N72.USD","BK1161","LU0359201612.USD","LU0128525689.USD","LU0149534421.HKD","IE00BZ08YS42.EUR","LU0128526141.USD","C","LU1791807156.HKD","LU0516423174.USD","IE00B543WZ88.USD","LU1074936037.SGD","BK1576","LU0181495838.USD","LU1244550221.USD","TFNS","LU0029874905.USD","IE00B5MMRT66.SGD","LU0051755006.USD","LU0477156953.USD","IE0008368742.USD","LU0648001328.SGD","LU0244354667.USD","LU0540923850.HKD","IE00B031HY20.USD","06978","LU0516422366.SGD","LU0052756011.USD","LU0348827113.USD","LU0588546209.SGD","09996","BK1589","LU0856984785.SGD","LU1831875114.USD","LU0327786744.USD","LU2097828557.USD","SG9999002562.SGD","LU1244550577.SGD","LU1226288170.HKD","LU2097828805.USD","LGHT","LU0979878070.USD","LU0320764599.SGD","LU2543165471.USD","AGNG","LU0140636845.USD","LU0823426480.USD","IE00BZ08YT58.USD","LU1880383366.USD","KURE","LU1993786604.SGD","LU2417539215.USD","LU0708995153.HKD","LU2462157665.USD","IEIH","LU1152091754.HKD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668869922","title":"Axsome's Auvelity Launch Shows Early Strength in Alzheimer's Agitation, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2668869922","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668869922?lang=en_us&edition=fundamental","pubTime":"2026-09-18 23:38","pubTimestamp":1789745882,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics'  investors remain focused on the launch of Auvelity for Alzheimer's agitation, RBC Capital Markets said Friday in a report.Early signs from the launch are encouraging, and Auvelity is on track to meet RBC's $804 million fiscal 2026 sales estimate and exceed Wall Street expectations, the 26-page report said.RBC's survey of 77 physicians, representing about 2,600 patients, found doctors like Auvelity's profile, expect to increase use, and are seeing steady patient growth.Physicians estimated that about one-third of their Alzheimer's agitation patients also have depression, which often leads doctors to start patients on Auvelity's full dose rather than the starter pack, a pattern that helps lift paid prescriptions and revenue, the report said.RBC maintained its outperform rating on Axsome and its $297 price target.Price: 210.42, Change: -3.86, Percent Change: -1.80","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","BK4585","PTH","AXSM","BK4007","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157650345","title":"Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1157650345","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157650345?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:58","pubTimestamp":1789732702,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (300642.SZ) has officially announced that its controlling subsidiaries, Jiangxi Tellgen Life Science Technology Co., Ltd. and Shanghai Maishi Biotechnology Co., Ltd., have...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","MDEV","BK1100","159883","IEIH","GDOC","300642","LGHT","BK1583","RSPH","MEDX","BK0046","PTH","BK0042","BK0239","BK1574","HART","LNGR","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668492827","title":"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668492827?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:30","pubTimestamp":1789731047,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-biomarin-pharmaceutical-bmrn-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-biomarin-pharmaceutical-bmrn-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BK4W5M84.HKD","LU1064131342.USD","LU1057294990.SGD","LU0345770993.USD","LU2456880835.USD","LU0943347566.SGD","LU0354030438.USD","LU0820561909.HKD","LU0234572021.USD","SG9999018865.SGD","GDOC","LU0114720955.EUR","LU0964807845.USD","LU2023250330.USD","LU2746668974.SGD","LU2236285917.USD","LU2361045086.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0094547139.USD","BK4007","LU0456855351.SGD","SGXZ51526630.SGD","ILDR","LU1868837300.USD","LU0672654240.SGD","LLYZ","LU0466842654.USD","LU2213496289.HKD","LU2361044949.HKD","LU0320765992.SGD","LU2746668461.USD","GB00BDT5M118.USD","LU1093756168.USD","SG9999015952.SGD","BK4581","SG9999018857.SGD","WDNA","LU2471134523.USD","LLY","LU2552382132.HKD","LU1035775433.USD","BK4534","IXJ","LU2361044865.SGD","SG9999014914.USD","LU1061106388.HKD","OZEM","LU2552382215.SGD","LU0708995401.HKD","LU1974910355.USD","IE0005OL40V9.USD","BK4533","LU0266013472.USD","LU0882574055.USD","LU2750360641.GBP","HRTS","LU2168564065.EUR","LU1989771016.USD","SG9999014880.SGD","CURE","LU1868836591.USD","AXSM","IE00BFSS8Q28.SGD","LU0096364046.USD","LU0198837287.USD","LU1548497426.USD","IE00BKPKM429.USD","LU0385154629.USD","LU2063271972.USD","LU0689472784.USD","LU2089284900.SGD","IE00BN29S564.USD","LU1291159041.SGD","IE00BFSS7M15.SGD","LU0256863902.USD","AGNG","IE0001KFT4U8.USD","LU2168563687.JPY","LU2756315318.SGD","IE00B1XK9C88.USD","SG9999001176.SGD","IE00BK4W5L77.USD","ELIS","LU0061475181.USD","IE0004445239.USD","BK4588","LU1868836757.USD","LU2023251221.USD","SGXZ81514606.USD","LU0058720904.USD","TMED","LU0353189680.USD","LU2271345857.HKD","LU0225283273.USD","IE00B19Z3B42.SGD","LU0320765059.SGD","SG9999017495.SGD","LU0432979614.USD","LU2461242641.AUD","LU2896262040.SGD","BK4599","LU1551013342.USD","LU1280957306.USD","LU0787776722.HKD","LU0353189763.USD","LU0106261372.USD","LU1629891620.HKD","LU2237438978.USD","IE00BWXC8680.SGD","LU0323591593.USD","BK4139","IE00B19Z3581.USD","IE00B7KXQ091.USD","LU1814569148.SGD","LU1712237335.SGD","SG9999014906.USD","IE00BJJMRY28.SGD","IYH","LU0471298694.HKD","LU2750360997.AUD","LU0823434740.USD","LU0640476718.USD","LU1127390331.HKD","LU2089283258.USD","RXL","SGXZ57979304.SGD","LU0316494557.USD","LU2168564222.USD","LU2237443622.USD","SGXZ31699556.SGD","LU2491050071.SGD","TRUH","LU0109394709.USD","LU2264538146.SGD","LU0210536198.USD","LU0354030511.USD","IE00B7SZLL34.SGD","LU1868836914.USD","LU2089984988.USD","LU2357305700.SGD","CANC","LU2462157665.USD","LU0882574139.USD","LU1979441026.SGD","LU2211815571.USD","BK4566","IE00B4JS1V06.HKD","IE0004445015.USD","LU1093756325.SGD","LLYX","IE00B775H168.HKD","IE00BKDWB100.SGD","SGXZ99366536.SGD","IE0002270589.USD","ELIL","LU1023059063.AUD","LU1983299246.USD","LU1623119135.USD","SG9999001176.USD","SG9999014898.SGD","LU1366192091.USD","LU0889565916.HKD","LU0158827781.USD","LU0174119429.USD","FTXH","LU1069344957.HKD","LU2112291526.USD","MEDI","SG9999013999.USD","LU2756315664.SGD","LU2111349929.HKD","LU0203201768.USD","BK4585","LU0256863811.USD","LU1232071149.USD","LU2491049909.HKD","LU0097036916.USD","LU2471134796.USD","LU0823434583.USD","PPH","LU0109391861.USD","IE00BJLML261.HKD","LU0345770308.USD","LU2237443465.HKD","LU2237443895.HKD","LU0820561818.USD","LU2237443978.SGD","LU1323610961.USD","SG9999015978.USD","IE0002141913.USD","LU2106854487.HKD","LU0823416689.USD","IHE","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU2087625088.SGD","LU2168564495.EUR","MEDX","LU2028103732.USD","LU0203202063.USD","LU0683600562.USD","LLII","LU0158827948.USD","LU2491050154.USD","LU2602419157.SGD","LU1917777945.USD","LU2417539215.USD","LU1720051017.SGD","LU0820562030.AUD","LU1267930730.SGD","JDOC","IE00BJT1NW94.SGD","LU2237443382.USD","LU2265009873.SGD","THNR","LU2168564149.EUR","LU2552382058.USD","LU0122379950.USD","LU1145028129.USD","VHT","LU2237443549.SGD","PJP","BMRN","PTH","LU0133085943.USD","LU0238689110.USD","LU1691799644.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU1988902786.USD","LU0289739699.SGD","LU2324357040.USD","SG9999015945.SGD","LU1551013425.SGD","IE0009355771.USD","LU2023250504.SGD","LU2108987350.USD","LU2471134879.HKD","IE00B1BXHZ80.USD","BK4505","FHLC","IE00B4R5TH58.HKD","LU0079474960.USD","LU1804176565.USD","LU1868837136.USD","LU0006306889.USD","LU2462591350.SGD","MHIP","SG9999015986.USD","LU1720051108.HKD","LU2471134952.CNY","BK4516","IE00BFTCPJ56.SGD","LU2360106947.USD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668928863","title":"Roivant Sciences Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2668928863","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668928863?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:15","pubTimestamp":1789730117,"startTime":"0","endTime":"0","summary":"Roivant Sciences holds annual shareholder meetingRoivant Sciences held its annual general meeting on Sept. 16, 2026.Shareholders backed the reappointment of Ernst & Young LLP as independent auditor fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL5J39Jd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ROIV","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990118","title":"Roivant Sciences Director Meghan FitzGerald Reports $203,159 Common Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990118","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990118?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:42","pubTimestamp":1789684974,"startTime":"0","endTime":"0","summary":"Roivant Sciences director Meghan FitzGerald reports $203,159 common share saleDirector Meghan FitzGerald sold 5,112 Roivant Sciences common shares on Sep. 15, 2026.Sales priced at USD 39.68 per share ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL2fxFl6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Roivant Sciences Director Meghan FitzGerald Reports $203,159 Common Share Sale","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668976309","title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","url":"https://stock-news.laohu8.com/highlight/detail?id=2668976309","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668976309?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:10","pubTimestamp":1789679402,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa sells 116 common shares for $20,300Guardant Health director Tariq Musa sold 116 common shares on Sep. 16, 2026 at USD 175.Directly held common stock fell to 11,449 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL5VHhJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","LU0320765992.SGD","BK4535","LU0889565916.HKD","HELX","BK4196","PTH","GNMX","BK4588","LU0109394709.USD","GDOC","GH","LFSC","EKG","FFOX","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668995985","title":"US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2668995985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668995985?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:20","pubTimestamp":1789658440,"startTime":"0","endTime":"0","summary":"UPDATE 6-US Health Secretary Kennedy Jr. adds eight new members to key health committeeSept 17 (Reuters)-US Health Secretary Robert F. Kennedy Jr. on Thursday named eight new members to the advisory p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N4591AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","GNOM","BK4588","GH","LU0109394709.USD","LU0320765992.SGD","BK4585","GDOC","PTH","BK4551","GNMX","EKG","BK4196","HELX","LU0889565916.HKD","LFSC","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998049","title":"Guardant Health on Track for Record High Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998049","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998049?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:16","pubTimestamp":1789654560,"startTime":"0","endTime":"0","summary":"Guardant Health, Inc.  is currently at $180.24, up $5.34 or 3.05%--Would be new all-time closing high --Would be the first new record closing high since Feb. 12, 2021, when it closed at $179.10--On pace for largest percent increase since Sept. 15, 2026, when it rose 4.65%--Currently up three of the past four days--Up 13.34% month-to-date--Up 76.46% year-to-date--Up 206.52% from 52 weeks ago , when it closed at $58.80--Would be a new 52-week closing high--Up 212.53% from its 52-week closing low of $57.67 on Sept. 24, 2025--Traded as high as $181.50; new all-time intraday high --Up 3.77% at today's intraday highAll data as of 10:14:03 AM ETSource: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Guardant Health on Track for Record High Close","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4196","LFSC","BK4585","GH","LU0889565916.HKD","LU0109394709.USD","HELX","GDOC","FFOX","BK4551","GNOM","GNMX","LU0320765992.SGD","BK4588","EKG","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961223","title":"Stifel Nicolaus Initiates Roivant Sciences With Buy Rating, $51 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961223","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961223?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:40","pubTimestamp":1789645253,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus Initiates Roivant Sciences With Buy Rating, $51 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTH","BK4007","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668690529","title":"Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2668690529","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668690529?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:00","pubTimestamp":1789642800,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  17, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/17/3363856/33090/en/axsome-therapeutics-presents-ten-posters-exemplifying-its-innovative-psychiatry-and-neurology-portfolio-at-psych-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","LU2324357040.USD","BK4585","CNS","BK4505","BK4135","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668782966","title":"Roivant Sciences Ltd : Stifel Initiates Coverage with Buy Rating; Target Price $51","url":"https://stock-news.laohu8.com/highlight/detail?id=2668782966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668782966?lang=en_us&edition=fundamental","pubTime":"2026-09-17 18:45","pubTimestamp":1789641905,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","BK4007","BK4139","PTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}